-+ 0.00%
-+ 0.00%
-+ 0.00%

MEDICENNA UPDATES MDNA11 CLINICAL TRIAL RESULTS AT THE ESMO-IO CONGRESS 2025, FURTHER BOLSTERING ITS ANTI-TUMOR ACTIVITY IN ADVANCED SOLID TUMORS

Reuters·12/10/2025 12:30:00

Please log in to view news